Treace Medical Concepts, Inc. TMCI EBITDA margin
EBITDA margin at other companies
Other financials
Where this comes from
Calculated from Treace Medical Concepts, Inc.’s reported figures.
Based on trailing twelve months.
The official record: Treace Medical Concepts, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Treace Medical Concepts, Inc.'s ebitda margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Treace Medical Concepts, Inc.'s EBITDA margin?
- Treace Medical Concepts, Inc. (TMCI) reported EBITDA margin of -22.5% in Q1 2026.
- How has Treace Medical Concepts, Inc.'s EBITDA margin changed year-over-year?
- Treace Medical Concepts, Inc.'s EBITDA margin decreased by 9.5% year-over-year, from -20.6% to -22.5%.
- What is the long-term trend for Treace Medical Concepts, Inc.'s EBITDA margin?
- Over 5 years (2020 to 2025), Treace Medical Concepts, Inc.'s EBITDA margin has grown at a 41.5% compound annual growth rate (CAGR), from 3.6% to -20.5%.
- What does EBITDA margin mean?
- EBITDA (earnings before interest, taxes, depreciation, and amortization) as a percentage of revenue, trailing twelve months. A proxy for cash operating profitability that strips out capital-structure and non-cash charges.